The company’s RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a proof-of-concept trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback